Skip to content
healthcare.dev

Everolimus

NDC 63850-0064, Everolimus, tablet, from Natco Pharma Limited.

Product NDC
63850-0064
Status
Listed
Labeler
Natco Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205432
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63850-0064 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS.75 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
63850-0064-2638500064026 BLISTER PACK in 1 CARTON (63850-0064-2) / 10 TABLET in 1 BLISTER PACK
63850-0064-66385000640660 TABLET in 1 BOTTLE (63850-0064-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d44998bb-5deb-4ee7-a0a5-979fe3f49557

Use it

Look up 63850-0064 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63850-0064 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63850-0064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.